Moody’s has also affirmed the “A3” rating on KDHCD’s outstanding revenue bonds.
The rating assignment is based on a number of factors, including KDHCD’s strong market position, excellent balance sheet and stable operating performance.
The outlook is stable, reflecting Moody’s expectation that KDHCD will continue to generate favorable cash flow and balance sheet metrics.
More articles on healthcare finance:
Cleveland Clinic sees operating margin slip to 7.2% as investments drag down bottom line
Gallup poll: Nearly 1 in 3 still delay medical care because of costs
Audit reveals $6M in equipment missing from LSU hospitals: 6 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
